Literature DB >> 8279457

Mycobacterium genavense. Autopsy findings in three patients.

H Maschek1, A Georgii, R E Schmidt, P Kirschner, E C Böttger.   

Abstract

The authors report on the pathologic findings in three cases of disseminated infection with Mycobacterium genavense, a recently described nontuberculous mycobacterium, in human immunodeficiency virus (HIV)-I-positive patients. The mycobacterium was identified by amplification of a 16S rDNA gene fragment and subsequent sequence determination. The organs mainly involved were the small intestine, spleen, liver, and lymph nodes. In contrast, lungs, myocardium, and kidneys were not involved, or only minimally involved, in this generalizing disease. Histopathologically, infection with Mycobacterium genavense in HIV-positive patients was mostly characterized by masses of foamy histiocytes and, depending on the immunologic reactivity of the host, by ill-formed granulomas, rarely with small foci of necrosis. The pathologic findings and clinical features were similar to those presented by patients who had generalized infection with Mycobacterium avium-intracellulare complex. To obtain more precise information about the specific course of infection with Mycobacterium genavense, scrupulous microbiologic investigations, including molecular biologic techniques, are necessary in cases with mycobacterial infections.

Entities:  

Mesh:

Year:  1994        PMID: 8279457     DOI: 10.1093/ajcp/101.1.95

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction.

Authors:  J M Dumonceau; A Van Gossum; M Adler; J P Van Vooren; P A Fonteyne; H De Beenhouwer; F Portaels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

2.  Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis.

Authors:  S Chou; P Chedore; S Kasatiya
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus.

Authors:  J M Dumonceau; P A Fonteyne; L Realini; A Van Gossum; J P Van Vooren; F Portaels
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.

Authors:  V O Thomsen; U B Dragsted; J Bauer; K Fuursted; J Lundgren
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 5.  Mycobacterium genavense: an emerging pathogen.

Authors:  E C Böttger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

6.  Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey.

Authors:  F Portaels; L Realini; L Bauwens; B Hirschel; W M Meyers; W de Meurichy
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Mycobacterium genavense infections in pet animals.

Authors:  T E Kiehn; H Hoefer; E C Bottger; R Ross; M Wong; F Edwards; N Antinoff; D Armstrong
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods.

Authors:  L Bosquée; E C Böttger; H De Beenhouwer; P A Fonteyne; B Hirschel; L Larsson; W M Meyers; J C Palomino; L Realini; L Rigouts
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

Review 9.  Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature.

Authors:  E Tortoli; F Brunello; A E Cagni; D Colombrita; D Dionisio; L Grisendi; V Manfrin; M Moroni; C Passerini Tosi; G Pinsi; C Scarparo; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.